Grothey A, Yaeger R, Paez D, Tabernero J, et al. ANCHOR CRC: a phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BINI), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC). Ann Oncol 2019;30 Suppl 4:iv109.
PMID: 32084963